| Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models E Caldas-Lopes, L Cerchietti, JH Ahn, CC Clement, AI Robles, A Rodina, ... Proceedings of the National Academy of Sciences 106 (20), 8368-8373, 2009 | 369 | 2009 |
| Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies W Luo, F Dou, A Rodina, S Chip, J Kim, Q Zhao, K Moulick, J Aguirre, ... Proceedings of the National Academy of Sciences 104 (22), 9511-9516, 2007 | 338 | 2007 |
| Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90 K Moulick, JH Ahn, H Zong, A Rodina, L Cerchietti, EM Gomes DaGama, ... Nature chemical biology 7 (11), 818-826, 2011 | 299 | 2011 |
| Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer A Rodina, M Vilenchik, K Moulick, J Aguirre, J Kim, A Chiang, J Litz, ... Nature chemical biology 3 (8), 498-507, 2007 | 202 | 2007 |
| Design, synthesis, and evaluation of small molecule Hsp90 probes T Taldone, D Zatorska, PD Patel, H Zong, A Rodina, JH Ahn, K Moulick, ... Bioorganic & medicinal chemistry 19 (8), 2603-2614, 2011 | 61 | 2011 |
| Effects of herbal products and their constituents on human cytochrome P4502E1 activity GM Raner, S Cornelious, K Moulick, Y Wang, A Mortenson, NB Cech Food and chemical toxicology 45 (12), 2359-2365, 2007 | 61 | 2007 |
| High-throughput screening fluorescence polarization assay for tumor-specific Hsp90 Y Du, K Moulick, A Rodina, J Aguirre, S Felts, R Dingledine, H Fu, ... SLAS Discovery 12 (7), 915-924, 2007 | 60 | 2007 |
| Emerging Hsp90 inhibitors: from discovery to clinic. G Chiosis, A Rodina, K Moulick Anti-Cancer Agents in Medicinal Chemistry 6 (1), 1-8, 2006 | 60 | 2006 |
| Combined Inhibition of NEDD8-Activating Enzyme and mTOR Suppresses NF2 Loss–Driven Tumorigenesis J Cooper, Q Xu, L Zhou, M Pavlovic, V Ojeda, K Moulick, E De Stanchina, ... Molecular cancer therapeutics 16 (8), 1693-1704, 2017 | 41 | 2017 |
| Synthesis of a red-shifted fluorescence polarization probe for Hsp90 K Moulick, CC Clement, J Aguirre, J Kim, Y Kang, S Felts, G Chiosis Bioorganic & medicinal chemistry letters 16 (17), 4515-4518, 2006 | 40 | 2006 |
| Anticancer Agents Med G Chiosis, A Rodina, K Moulick Chem 6, 1-8, 2006 | 10 | 2006 |
| Design of a flexible cell-based assay for the evaluation of heat shock protein 70 expression modulators JH Ahn, W Luo, J Kim, A Rodina, CC Clement, J Aguirre, W Sun, Y Kang, ... Assay and drug development technologies 9 (3), 236-246, 2011 | 3 | 2011 |
| Effects of Echinacea on human metabolizing systems. K Moulick, G Raner American Chemical Society (ACS), 2003 | 3 | 2003 |
| Biochemical evidence towards the existence of an oncogenic Hsp90 complex A Rodina, K Moulick, J Ahn, H Zong, L Cerchietti, EG DaGama, ... Cancer Research 72 (8_Supplement), 3029-3029, 2012 | 1 | 2012 |
| Abstract# LB-86: Probing cancer-specific activating signaling pathways through a tumor-specific Hsp90 inhibitor K Moulick, J Ahn, K Beebe, Y Ma, D Zartoska, T Taldone, E Caldas-Lopez, ... Cancer Research 69 (9_Supplement), LB-86-LB-86, 2009 | 1 | 2009 |
| Correction: Combined Inhibition of NEDD8-activating Enzyme and mTOR Suppresses NF2 Loss-driven Tumorigenesis J Cooper, Q Xu, L Zhou, M Pavlovic, V Ojeda, K Moulick, E de Stanchina, ... Molecular cancer therapeutics 20 (2), 450, 2021 | | 2021 |
| Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90 EM Gomes-DaGama, K Moulick, JH Ahn, H Zong, A Rodina, L Cerchietti, ... Cancer Research 72 (8_Supplement), 1263-1263, 2012 | | 2012 |
| High-throughput screening fluorescence polarization assay for tumor-specific Hsp90 K Moulick, Y Du, J Aguirre, S Felts, R Dingledine, H Fu, G Chiosis Cancer Research 67 (9_Supplement), LB-301-LB-301, 2007 | | 2007 |
| Targeting basal-like breast cancer via purine-scaffold Hsp90 inhibitors E Lopes, K Joungnam, A Rondina, K Moulick, G Chiosis Cancer Research 67 (9_Supplement), 3964-3964, 2007 | | 2007 |
| Identification of potent water soluble purine-scaffold inhibitors of the heat shock protein 90 K Moulick, H He, D Zatorska, J Kim, J Aguirre, N Wu, Y She, R Immormino, ... CANCER RESEARCH 66 (8), 2006 | | 2006 |
